Survival in hepatitis C and HIV co-infection: A cohort study of hospitalized veterans

被引:21
作者
El-Serag, HB
Giordano, TP
Kramer, J
Richardson, P
Souchek, J
机构
[1] Baylor Coll Med, Houston Ctr Qual Care & Utilizat Studies, Houston Vet Affairs Med Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Gastroenterol Sect, Houston, TX 77030 USA
[3] Baylor Coll Med, Infect Dis Sect, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
关键词
D O I
10.1016/S1542-3565(04)00620-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Previous studies reported increased morbidity and mortality related to liver disease among human immunodeficiency virus (HIV)-infected patients with hepatitis C co-infection. However, the longterm effect of hepatitis C virus (HCV) co-infection on the mortality of HIV-infected patients remains unclear. Methods: By using national Veterans Affairs (VA) databases, we performed a retrospective cohort study of HIV patients hospitalized between October :1991 and September 2000. Mortality rates and hazard rate ratios (HRRs) for mortality were calculated for the entire cohort as well as after excluding patients with pre-existing liver disease, with follow-up through September 2001 after discharge. Multivariable adjustment for differences in demographics, comorbidities, and HIV disease severity was performed. Separate analyses were performed for patients identified during the highly active antiretroviral therapy (HAART) era. Results: We identified 18,08:1 patients, of whom 5320 patients had dual HCV/HIV infection and 1.2,761 patients had HIV monoinfection. The number of deaths per 100 patient-years was 7.33 in the dual infection group and 14.13 in the HIV monoinfection group during 22,054 and 40,655 person-years of follow-up, respectively. The mortality rate ratio between HCV/HIV dual infection and HIV monoinfection was .53. In Cox multiple regression, the dual HCV/HIV infection group had an adjusted HRR for mortality of.55 compared with the HIV monoinfection group (95% Cl, .51.58, P < .0001), after controlling for age, race, sex, year of diagnosis, and HIV disease severity. These findings persisted in several sensitivity analyses. However, in the HAART era, if patients with liver disease at baseline were excluded, the HRR for mortality was .83 (95% Cl, .73-.94, P =.003). Conclusions: Co-infection with hepatitis C is associated with a significant decrease in the mortality of HIV-infected patients. However, this effect was less pronounced during the HAART era.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 33 条
[1]  
Berger A, 1996, J MED VIROL, V48, P339, DOI 10.1002/(SICI)1096-9071(199604)48:4&lt
[2]  
339::AID-JMV7&gt
[3]  
3.0.CO
[4]  
2-8
[5]   Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection [J].
Bica, I ;
McGovern, B ;
Dhar, R ;
Stone, D ;
McGowan, K ;
Scheib, R ;
Snydman, DR .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) :492-497
[6]   Limited success of HCV antiviral therapy in United States veterans [J].
Cawthorne, CH ;
Rudat, KR ;
Burton, MS ;
Brown, KE ;
Luxon, BA ;
Janney, CG ;
Fimmel, CJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (01) :149-155
[7]   HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype [J].
Cribier, B ;
Schmitt, C ;
Rey, D ;
Uhl, G ;
Lang, JM ;
Vetter, D ;
Kirn, A ;
StollKeller, F .
RESEARCH IN VIROLOGY, 1997, 148 (04) :267-271
[8]   ASCERTAINMENT OF VITAL STATUS THROUGH THE NATIONAL DEATH INDEX AND THE SOCIAL-SECURITY-ADMINISTRATION [J].
CURB, JD ;
FORD, CE ;
PRESSEL, S ;
PALMER, M ;
BABCOCK, C ;
HAWKINS, CM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 121 (05) :754-766
[9]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[10]  
DI MV, 2000, HEPATOLOGY, V34, P1193